Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 5
1983 1
1984 3
1985 1
1986 7
1987 2
1988 3
1989 6
1990 1
1991 1
1992 2
1993 1
1994 4
1995 2
1996 3
1997 2
1998 2
1999 3
2003 3
2004 1
2005 1
2008 2
2009 2
2010 1
2011 1
2012 1
2017 3
2019 2
2020 3
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Preclinical pharmacology of milnacipran.
Briley M, Prost JF, Moret C. Briley M, et al. Among authors: prost jf. Int Clin Psychopharmacol. 1996 Sep;11 Suppl 4:9-14. doi: 10.1097/00004850-199609004-00002. Int Clin Psychopharmacol. 1996. PMID: 8923122 Review.
Efficacy and tolerability of milnacipran: an overview.
Montgomery SA, Prost JF, Solles A, Briley M. Montgomery SA, et al. Among authors: prost jf. Int Clin Psychopharmacol. 1996 Sep;11 Suppl 4:47-51. doi: 10.1097/00004850-199609004-00007. Int Clin Psychopharmacol. 1996. PMID: 8923127 Review.
Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression.
Prat M, Le Naour A, Coulson K, Lemée F, Leray H, Jacquemin G, Rahabi MC, Lemaitre L, Authier H, Ferron G, Barret JM, Martinez A, Ayyoub M, Delord JP, Gladieff L, Tabah-Fisch I, Prost JF, Couderc B, Coste A. Prat M, et al. Among authors: prost jf. J Immunother Cancer. 2020 Jun;8(1):e000472. doi: 10.1136/jitc-2019-000472. J Immunother Cancer. 2020. PMID: 32503947 Free PMC article.
Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples.
Ho-Pun-Cheung A, Bazin H, Boissière-Michot F, Mollevi C, Simony-Lafontaine J, Landas E, Bleuse JP, Chardès T, Prost JF, Pèlegrin A, Jacot W, Mathis G, Lopez-Crapez E. Ho-Pun-Cheung A, et al. Among authors: prost jf. Br J Cancer. 2020 Feb;122(3):397-404. doi: 10.1038/s41416-019-0670-8. Epub 2019 Dec 3. Br J Cancer. 2020. PMID: 31792349 Free PMC article.
ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C, Lazrek Y, Dubreuil O, Sampaio C, Larbouret C, Lanotte R, Poul MA, Barret JM, Prost JF, Pèlegrin A, Chardès T. Le Clorennec C, et al. Among authors: prost jf. Cell Commun Signal. 2019 Aug 23;17(1):106. doi: 10.1186/s12964-019-0413-8. Cell Commun Signal. 2019. PMID: 31443721 Free PMC article.
Prophylaxis and therapy for Chikungunya virus infection.
Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S, Prost JF, Lecuit M. Couderc T, et al. Among authors: prost jf. J Infect Dis. 2009 Aug 15;200(4):516-23. doi: 10.1086/600381. J Infect Dis. 2009. PMID: 19572805 Free PMC article.
Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia.
Georges JL, Gilles F, Cochet H, Bertrand A, De Tournemire M, Monguillon V, Pasqualini M, Prevot A, Roger G, Saba J, Soltani J, Koukabi-Fradelizi M, Beressi JP, Laureana C, Prost JF, Livarek B. Georges JL, et al. Among authors: prost jf. PLoS One. 2020 Dec 21;15(12):e0244349. doi: 10.1371/journal.pone.0244349. eCollection 2020. PLoS One. 2020. PMID: 33347477 Free PMC article.
The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer.
Barret JM, Nicolas A, Jarry A, Dubreuil O, Meseure D, Passat T, Perrial E, Deleine C, Champenois G, Gaillard S, Duchalais E, Ray-Coquard I, Lahmar M, Dumontet C, Bennouna J, Bossard C, Roman-Roman S, Prost JF. Barret JM, et al. Among authors: prost jf. Biology (Basel). 2021 Apr 7;10(4):305. doi: 10.3390/biology10040305. Biology (Basel). 2021. PMID: 33917111 Free PMC article.
70 results